Shi, Galen H.
Connor, Robert J.
Collins, David S.
Kang, David W.
Article History
Received: 25 September 2020
Accepted: 13 November 2020
First Online: 6 January 2021
Compliance with Ethical Standards
:
: Galen H. Shi and David S. Collins are employees of and hold shares in Eli Lilly and Company. Robert J. Connor is a former employee of and holds shares in Halozyme Therapeutics, Inc. David W. Kang is an employee of and holds shares in Halozyme Therapeutics, Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The clinical study protocol was approved by the Institutional Review Board (IRB) of Eli Lilly and Company. All animal experiments were conducted in full compliance with local, national, ethical, and regulatory principles and local licensing regulations under approved Institutional Animal Care and Use Committee (IACUC) protocols following United States Department of Agriculture (USDA) guidelines and regulations for research.
: Informed consent was obtained from all individual participants included in the clinical study.
: Halozyme Therapeutics, Inc., follows policies established by the International Committee of Medical Journal Editors. The miniature pig studies were conducted by Halozyme Therapeutics, Inc., and the data are held by both Halozyme Therapeutics, Inc. and Eli Lilly and Company. The clinical study was conducted by Eli Lilly and Company and the clinical study data are held by the company. Additional information about the studies and/or datasets can be obtained by contacting Halozyme Therapeutics, Inc.: 11388 Sorrento Valley Road, San Diego, CA, 92121, USA; Phone: +1.858.794.8889; Email: publications@halozyme.com.